ED90 of 0.75% Bupivacaine for Bilateral Tubal Ligation (BTL)
NCT05017584
·
clinicaltrials.gov ↗
PHASE4
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Study halted prematurely, prior to enrollment of first participant
Conditions
Pain
Interventions
DRUG:
Hyperbaric bupivacaine
Sponsor
Duke University